FDA Inspection 898075 — ThromboGenics, Inc.
The FDA completed an inspection of ThromboGenics, Inc. on Sep 19, 2014 in Iselin, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 19, 2014
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Iselin, NJ (United States)
Additional details
Postmarket Adverse Drug Experience (PADE)